María Pascual‐Lucas
María Pascual‐Lucas publishes mostly in Physiology, Psychiatry and Mental health and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Amyloidosis: Diagnosis, Treatment, Outcomes.
- World rank
- #1,246,105 of 7,710,434 ranked researchers
- Rank in Spain
- #25,354 of 204,306
- Works
- 24
- Citations
- 1.4k
- Citations per work
- 57.6
What does María Pascual‐Lucas research?
María Pascual‐Lucas's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (19%), Neuroscience (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1250.0%
- Medicine1250.0%
- Everything else625.7%
- Life Sciences624.3%
- 1Physiology24% of their works
- 2Psychiatry and Mental health19% of their works
- 3Molecular Biology14% of their works
- 4Pharmacology7% of their works
- 5Neurology6% of their works
- 6Genetics4% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Neuroinflammation and Neurodegeneration Mechanisms
- Cholinesterase and Neurodegenerative Diseases
- Genetics and Neurodevelopmental Disorders
- Histone Deacetylase Inhibitors Research
- Phosphodiesterase function and regulation
Which keywords describe María Pascual‐Lucas's research?
The keywords of their largest research topics: Neurodegeneration, Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Dementia, Mild Cognitive Impairment and Brain Development.
- cAMP Signaling
- HDAC Inhibitors
- Rett Syndrome
- Transthyretin
- Cholinesterase Inhibitors
- Astrocytes
- Brain Development
- Dementia
- Tau Pathology
- Neuroinflammation
- Neurodegeneration
- Amyloid Hypothesis
- Alzheimer's Disease
- Mild Cognitive Impairment
- Acetylcholinesterase
- Cardiac Amyloidosis
- Microglia
- Fragile X Syndrome
- Cyclic Nucleotide Phosphodiesterases
- Histone Deacetylases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neurodegeneration212 topics
- Neuroinflammation212 topics
- Amyloid Hypothesis171 topic
- Tau Pathology171 topic
- Alzheimer's Disease152 topics
- Dementia111 topic
- Mild Cognitive Impairment111 topic
- Brain Development72 topics
- Acetylcholinesterase41 topic
- Astrocytes41 topic
- Cardiac Amyloidosis41 topic
- Cholinesterase Inhibitors41 topic
- Microglia41 topic
- Transthyretin41 topic
- Fragile X Syndrome31 topic
- Rett Syndrome31 topic
- Cyclic Nucleotide Phosphodiesterases21 topic
- HDAC Inhibitors21 topic
- Histone Deacetylases21 topic
- cAMP Signaling21 topic
Where does María Pascual‐Lucas work?
María Pascual‐Lucas's main affiliation in the publication record is Grifols (Spain), Spain.
How many publications and citations does María Pascual‐Lucas have?
OpenAlex counts 24 works and 1,383 citations for María Pascual‐Lucas, an h-index of 11, ranking #1,246,105 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about María Pascual‐Lucas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.